The long term goal of this research is to test the hypothesis that FSH receptor binding competitors (FRBC) can regulate the biological action of FSH, and are therefore essential components in the control of normal developmental, physiologic, and patholophysiologic functions of the gonad. The immediate focus of the studies proposed here is to purify and characterize a 58,000 MW FRBC that was first identified in follicular fluid by its binding to FSH receptors and antisera, and by its biological action as an FSH agonist in vitro. Furthermore, FRBC is antigenically and biochemically related to the precursor protein (58,00 MW) of the alpha inhibin subunit, also of gonadal origin, suggesting the possibility that regulation of FRBC posttranslational processing can modulate FSH biological action at the gonadal FSH receptor in a novel way.
Specific Aim 1 involves further purification and characterization of FRBC, confirmation of bioactivity, and microsequencing to affirm the relationship of FRBC to alpha inhibin precursor. Specific monoclonal antibodies to different regions of FRBC will be raised to improve purification, and permit immunochemical detection of FRBC or its fragments in subsequent aims.
Specific Aim 2 will explore the anatomical distribution of FRBC, as well as the hormonal regulation of synthesis, processing and secretion of FRBC using primary cultures of gonadal cells responsible for producing and secreting FRBC.
Specific Aim 3 uses antibodies and FRBC from Aim 1 that are characterized in Aim 2 to develop specific assays for FRBC in serum and follicular fluid in patients with FSH-related reproductive disorders. Results from these studies should 1) confirm the existence of a local FSH regulatory system, 2) provide probes for studying the biochemistry and physiological role of FRBC, 3) elucidate regulatory mechanisms for posttranslational processing of FRBC, 4) explore the exciting interrelationship between FRBC, and FSH agonist, and alpha inhibin, which is responsible for suppressing FSH levels, and 5) evaluate the role of FRBC in human reproductive physiology, especially in control of gametogenesis and a potential role of FRBCs in disease states such as premature ovarian failure.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025941-02
Application #
3327220
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1990-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Puls, L E; Hamous, J; Morrow, M S et al. (1994) Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol Oncol 54:396-401
Sluss, P M; Gentile, D P; Ewing, J F et al. (1993) Multiple molecular weight forms of immunoreactive alpha-inhibin in human seminal plasma. J Clin Endocrinol Metab 76:476-83
Santoro, N; Schneyer, A L; Ibrahim, J et al. (1992) Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol 79:579-85
Sluss, P M; Schneyer, A L (1992) Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab 74:1242-6
Schneyer, A L; O'Neil, D A; Crowley Jr, W F (1992) Activin-binding proteins in human serum and follicular fluid. J Clin Endocrinol Metab 74:1320-4
Schneyer, A L; Sluss, P M; Whitcomb, R W et al. (1991) Development of a radioligand receptor assay for measuring follitropin in serum: application to premature ovarian failure. Clin Chem 37:508-14
Schneyer, A L; Sluss, P M; Whitcomb, R W et al. (1991) Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology 129:1987-99
Whitcomb, R W; Schneyer, A L; Roser, J F et al. (1991) Circulating antagonist of luteinizing hormone in association with infertility in stallions. Endocrinology 128:2497-502
Bernstein, J R; Crowley Jr, W F; Schneyer, A L (1990) An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod 43:492-6
Whitcomb, R W; Schneyer, A L (1990) Development and validation of a radioligand receptor assay for measurement of luteinizing hormone in human serum. J Clin Endocrinol Metab 71:591-5